Congratulations to our CEO and founder Cathy Bouvier, who is the new president of INCA!
Simone Leyden’s term as INCA President came to an end and passed the torch to our CEO, Cathy Bouvier. Simone’s leadership and the dedicated board of directors have been instrumental in achieving great progress and new milestones for INCA, thank you. Cathy is very much going to be focussing on building on this momentum.
“I am honoured to be given the opportunity to drive forward the ongoing work of INCA. During my term as INCA President, I hope to see growth across all our 3 strategic pillars through truly collaborative cross functional working. This will lead to improving impact and outcomes for patients who follow a less common pathway, establishing patient experience as being on a par with clinical effectiveness and safety, the provision of standardised useful and accurate patient information, an increase in patient driven research, our membership, education and awareness across this diverse and complex disease area.
INCA is the global voice and umbrella organisation for the Neuroendocrine Cancer and Genetic Neuroendocrine Tumour Community recognising the exceptional work done nationally/locally by both our membership organisations and individual patient advocates.
As the well-known saying goes: ‘if you want go fast, go alone, but if you want to far, go together’, and I very much intend for a united approach, and look forward to working together to improve outcomes for all.”
